BREATHLEssness in INDIA (BREATHE-INDIA)-Study protocol for the co-design of a community breathlessness intervention in India using realist methods and intervention mapping.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 07 03 2023
accepted: 21 10 2023
medline: 6 11 2023
pubmed: 2 11 2023
entrez: 2 11 2023
Statut: epublish

Résumé

Breathlessness that persists despite treatment of causal disease(s) is disabling, associated with high therapy-related costs and poor socioeconomic outcomes. Low resource countries bear a disproportionate burden of respiratory problems, often characterised by disabling breathlessness. Low-cost self-management breathlessness-targeted interventions are effective and deliverable in community settings but have been developed in high-income countries. We aim to understand how breathlessness self-management works in 'real life' populations and cultural contexts, to develop programme theory and co-design a prototype intervention to improve persistent breathlessness management in India. Using a Realist approach, Intervention Mapping and the Medical Research Council Complex Intervention Framework we will undertake two phases of work supported by our Expert Group (of respiratory, primary, palliative care physicians) and key stakeholder groups (opinion leader clinicians, community health workers and people with lived experiences of breathlessness). 1) Realist review and evaluation to identify and refine evidence and theory for breathlessness self-management, producing intervention and implementation programme theory. We will identify literature through our Expert Group, scoping searches and systematic searches (Medline, Ebscohost, CINAHL, Scopus, Psychinfo). We will map intervention components to 'what works, for whom, and where.' 2) Intervention development using Intervention Mapping to map intervention and implementation programme theory to intervention components, develop materials to support intervention delivery, and co-design a prototype educational intervention ready for early acceptability and delivery-feasibility testing and evaluation planning in India. Use of stakeholder groups is to allow people with experience of breathlessness and/or its management to contribute their views on content developed by our team based upon review of secondary data sources. Experts and Stakeholders are therefore not research subjects but are included as extended members of the study team and will not follow informed consent procedures. Experts and stakeholders will be acknowledge in outputs arising from our project if they wish to be. Our review conduct will be consistent with RAMESES quality standards. At the conclusion of our study, we will have co-designed a breathlessness intervention for use in the community setting in India ready for further evaluation of: effectiveness, socioeconomic outcomes, acceptability and transferability to other low resource settings.

Sections du résumé

BACKGROUND
Breathlessness that persists despite treatment of causal disease(s) is disabling, associated with high therapy-related costs and poor socioeconomic outcomes. Low resource countries bear a disproportionate burden of respiratory problems, often characterised by disabling breathlessness. Low-cost self-management breathlessness-targeted interventions are effective and deliverable in community settings but have been developed in high-income countries. We aim to understand how breathlessness self-management works in 'real life' populations and cultural contexts, to develop programme theory and co-design a prototype intervention to improve persistent breathlessness management in India.
METHODS AND ANALYSIS
Using a Realist approach, Intervention Mapping and the Medical Research Council Complex Intervention Framework we will undertake two phases of work supported by our Expert Group (of respiratory, primary, palliative care physicians) and key stakeholder groups (opinion leader clinicians, community health workers and people with lived experiences of breathlessness). 1) Realist review and evaluation to identify and refine evidence and theory for breathlessness self-management, producing intervention and implementation programme theory. We will identify literature through our Expert Group, scoping searches and systematic searches (Medline, Ebscohost, CINAHL, Scopus, Psychinfo). We will map intervention components to 'what works, for whom, and where.' 2) Intervention development using Intervention Mapping to map intervention and implementation programme theory to intervention components, develop materials to support intervention delivery, and co-design a prototype educational intervention ready for early acceptability and delivery-feasibility testing and evaluation planning in India. Use of stakeholder groups is to allow people with experience of breathlessness and/or its management to contribute their views on content developed by our team based upon review of secondary data sources. Experts and Stakeholders are therefore not research subjects but are included as extended members of the study team and will not follow informed consent procedures. Experts and stakeholders will be acknowledge in outputs arising from our project if they wish to be. Our review conduct will be consistent with RAMESES quality standards.
DISCUSSION
At the conclusion of our study, we will have co-designed a breathlessness intervention for use in the community setting in India ready for further evaluation of: effectiveness, socioeconomic outcomes, acceptability and transferability to other low resource settings.

Identifiants

pubmed: 37917762
doi: 10.1371/journal.pone.0293918
pii: PONE-D-23-04945
pmc: PMC10621994
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0293918

Subventions

Organisme : Medical Research Council
ID : MR/X503034/1
Pays : United Kingdom

Informations de copyright

Copyright: © 2023 Clark et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

BMC Pulm Med. 2022 Mar 18;22(1):93
pubmed: 35303861
ERJ Open Res. 2021 Oct 11;7(4):
pubmed: 34651042
CA Cancer J Clin. 2020 Aug 25;:
pubmed: 32964460
J Adv Nurs. 2021 Apr;77(4):1698-1715
pubmed: 33615544
J Pain Symptom Manage. 2019 Jun;57(6):1051-1061.e1
pubmed: 30802635
BMJ Open Respir Res. 2022 Feb;9(1):
pubmed: 35172985
Eur Respir J. 2017 May 25;49(5):
pubmed: 28546269
Indian J Palliat Care. 2021 Jan-Mar;27(1):54-61
pubmed: 34035618
Indian J Palliat Care. 2019 Jul-Sep;25(3):403-406
pubmed: 31413456
Eur Respir J. 2017 Aug 17;50(2):
pubmed: 28818884
Implement Sci. 2015 Sep 28;10:134
pubmed: 26415961
Lancet Glob Health. 2022 Jan;10(1):e63-e76
pubmed: 34919858
J Pain Symptom Manage. 2010 May;39(5):831-8
pubmed: 20471544
Palliat Med Rep. 2020 Aug 18;1(1):166-170
pubmed: 34223472
Chest. 2000 Apr;117(4):935-43
pubmed: 10767221
Soc Sci Med. 2018 Mar;201:136-147
pubmed: 29518580
Curr Opin Support Palliat Care. 2022 Dec 1;16(4):210-215
pubmed: 36102933
J Tradit Complement Med. 2016 Feb 28;7(1):50-53
pubmed: 28053888
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
Int J Tuberc Lung Dis. 2021 Oct 1;25(10):846-853
pubmed: 34615582
Implement Sci. 2020 Mar 12;15(1):17
pubmed: 32164692
Lancet Glob Health. 2018 Dec;6(12):e1339-e1351
pubmed: 30219317
Expert Rev Respir Med. 2021 Dec;15(12):1563-1577
pubmed: 34595990
Adv Exp Med Biol. 2021;1343:39-55
pubmed: 35015276
Eur Respir J. 2018 Feb 21;51(2):
pubmed: 29467199
NPJ Prim Care Respir Med. 2019 Nov 29;29(1):41
pubmed: 31784524
Respir Res. 2019 Dec 21;20(1):291
pubmed: 31864411
BMC Med. 2013 Jan 29;11:21
pubmed: 23360677
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
BMJ Open. 2020 Sep 3;10(9):e037636
pubmed: 32883731
Patient Educ Couns. 2015 Feb;98(2):182-90
pubmed: 25468399
Implement Sci. 2015 Oct 28;10:149
pubmed: 26510493
BMJ Glob Health. 2019 Oct 31;4(5):e001638
pubmed: 31749993
NPJ Prim Care Respir Med. 2017 Apr 21;27(1):27
pubmed: 28432286

Auteurs

Joseph Clark (J)

Wolfson Palliative Care Research Centre, University of Hull, Hull, United Kingdom.

Naveen Salins (N)

Department of Palliative Medicine and Supportive Care, Kasturba Medical College Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Mark Pearson (M)

Wolfson Palliative Care Research Centre, University of Hull, Hull, United Kingdom.

Anna Spathis (A)

Department of Public Health and Primary Care, University of Cambridge, United Kingdom.

David C Currow (DC)

Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, Australia.

Siân Williams (S)

Joint Chief Executive Officer, International Primary Care Respiratory Group, London, United Kingdom.

Miriam Johnson (M)

Wolfson Palliative Care Research Centre, University of Hull, Hull, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH